M. Gil Gil - Med Oncol, Inst Catala Oncol

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 20 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Neoadjuvant Letrozole and Palbociclib in Patients with HR-positive/HER2-negative Early Breast Cancer and Oncotype DX Recurrence Score ≥18: DxCARTES Study

Á Guerrero-Zotano,J M Pérez-García,M Ruiz-Borrego,B Bermejo,M Gil-Gil,J de la Haba,E Alba Conejo,V Quiroga,V Carañana,A Urruticoechea,S Morales, M Bellet,A Antón,M Fernández-Abad,P Sánchez-Rovira, L Calabuig, J Pérez-Escuredo,M Sampayo-Cordero, J Cortés,A Llombart-Cussac

ESMO openno. 10 (2024): 103733-103733

引用0浏览0WOS引用

Tumor-Infiltrating Lymphocytes and Its Relationship with Survival in a Series of Primary Breast Cancer Patients According to the Different Surrogated Molecular Subtypes

C. Falo Zamora,J. Azcarate,A. Petit,S. Fernandez-Gonzalez,A. Garcia-Tejedor,A. Vethencourt,S. Vazquez,H. Perez Montero,M. Laplana,E. Martinez, R. Taco,E. Guerra,M. Varela, F. J. Perez,A. Stradella,M. J. Pla,M. Gil-Gil,S. Pernas,R. Ortega,T. Soler-Monso

European Journal of Cancer (2022): S96-S96

引用0浏览0引用

Histological patterns of response to neoadjuvant chemotherapy in breast cancer and breast conservation

M-J Pla Farnos,A. Garcia Tejedor,M. E. Fernandez Montoli,M. Campos Delgado,T. Soler Monso,A. Petit Montserrar,I. Morilla Ruiz,M. Gil Gil,C. Falo Zamora,R. Ortega Martinez,A. Guma Martinez, X. Perez Martin,J. Ponce Sebastia

CANCER RESEARCH（2019）

引用0浏览0引用

Abstract P3-12-01: 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitors (ais) in the Adjuvant Setting. A Phase II Prospective, Randomized, Double-Blind Placebo-Controlled Study - “the Blissafe Study”

P Sánchez-Rovira,AL Hirschberg,M Gil-Gil,S Antolín-Novoa,L García-Estévez,B Bermejo de las Heras,J Presa-Lorite, I Sánchez-Vigil de la Villa,J Suárez-Almarza,C Nieto-Magro

Cancer research（2018）

引用1浏览0引用

Abstract P2-09-11: PAM50 Intrinsic Subtyping As a Predictor of Pathological Complete Response to Neoadjuvant Trastuzumab-Based Chemotherapy in Early HER2-positive Breast Cancer

S Pernas,A Petit,F Climent,L Pare,J Perez-Martin,L Ventura,P Galvan,C Falo,I Morilla,A Fernandez-Ortega,A Stradella,T Pascual,M Gil-Gil,A Prat

Cancer Researchno. 4_Supplement (2018): P2-09

引用0浏览0引用

‘Real World Data’ of Genomic Sequencing for Personalised Therapy

M. S. Bergamino,A. Vethencourt,A. Stradella,S. Recalde,C. Fabregat,S. Vazquez,C. Falo,A. Fernandez-Ortega,R. Villanueva Vazquez, M. E. Ferrer Cardona, S. Rubio,M. Gil-Gil

Annals of Oncology（2018）

引用0浏览0WOS引用

SEOM Clinical Guidelines for Diagnosis and Treatment of Glioblastoma (2017)

M. Martínez-Garcia,J. Álvarez-Linera,C. Carrato,L. Ley,R. Luque,X. Maldonado, M. Martínez-Aguillo,L. M. Navarro,M. A. Vaz-Salgado,M. Gil-Gil

Clinical & Translational Oncologyno. 1 (2017): 22-28

引用54浏览0WOS引用

A phase II prospective, randomized, double-blind, placebo-controlled multi-centre clinical trial to assess the safety of 0.005% estriol vaginal gel in hormone receptor-positive postmenopausal women with early stage breast cancer in treatment with aromatase inhibitors (AIs) in the adjuvant setting - Initial safety results

P. Sanchez Rovira,M. Gil Gil, J. Presa Lorita, J. Suarez Almarza,C. Nieto Magro

EUROPEAN JOURNAL OF CANCER（2016）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn